HilleVax
www.hillevax.comHilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
Read more
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
Read more
Country
State
Massachusetts
City (Headquarters)
Boston
Industry
Employees
11-50
Founded
2021
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President Human Resources
Email ****** @****.comPhone (***) ****-****Co - Founder , Chief Executive Officer and Chairman of the Board
Email ****** @****.comPhone (***) ****-****Chief Operations Officer and Co - Founder
Email ****** @****.comPhone (***) ****-****General Counsel and Chief Administrative Officer
Email ****** @****.comPhone (***) ****-****
Reach decision makers at HilleVax
Free credits every month!
HilleVax FAQ
Boston, United States
Biotechnology Research
